E-Z-EM to expand Canadian subsidiary
Due to growth in its pharmaceutical and contrast manufacturing business, contrast agent developer E-Z-EM plans to expand the facilities of its Canadian subsidiary, E-Z-EM Canada. The Westbury, NY, company will rent an additional 46,000 square feet
Due to growth in its pharmaceutical and contrast manufacturing business, contrast agent developer E-Z-EM plans to expand the facilities of its Canadian subsidiary, E-Z-EM Canada. The Westbury, NY, company will rent an additional 46,000 square feet adjacent to E-Z-EM Canadas existing 70,000-square-foot facility in Montreal. E-Z-EM Canada will occupy the new site in March, and has the option to lease additional space or buy the facility in the future. E-Z-EM Canada attributed its need for a larger site to increased sales of its major product lines in the past two years, according to Pierre-Andre Ouimet, president.
New PET Study Links Higher Education Level to Speed of Tau Accumulation with Alzheimer’s Disease
July 8th 2025For patients with amyloid β (Aβ)-positive findings on positron emission tomography, higher educational attainment was associated with accelerated accumulation and spread of tau, according to new research.
